Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients

Rifaximin is a poorly absorbable antibiotic against hepatic encephalopathy (HE). This observational study aimed to elucidate the effect of rifaximin on intestinal permeability and gut microbiota in patients with decompensated cirrhosis. Thirty patients with decompensated cirrhosis were assessed by a...

Full description

Saved in:
Bibliographic Details
Main Authors: Kosuke Kaji (Author), Soichiro Saikawa (Author), Hiroaki Takaya (Author), Yukihisa Fujinaga (Author), Masanori Furukawa (Author), Koh Kitagawa (Author), Takahiro Ozutsumi (Author), Daisuke Kaya (Author), Yuki Tsuji (Author), Yasuhiko Sawada (Author), Hideto Kawaratani (Author), Kei Moriya (Author), Tadashi Namisaki (Author), Takemi Akahane (Author), Akira Mitoro (Author), Hitoshi Yoshiji (Author)
Format: Book
Published: MDPI AG, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available